
How to Read a Testosterone Lab Panel: Total, Free, and What They Mean
Total testosterone, free testosterone, SHBG, LH, and FSH each answer a different question. Here is how clinicians read them together, and why one number is never enough.
Read MoreExpert insights on health, wellness, and the latest in medical treatments from the NoMi Beach Health team.

Total testosterone, free testosterone, SHBG, LH, and FSH each answer a different question. Here is how clinicians read them together, and why one number is never enough.
Read More
Sauna has surprisingly good long-term outcome data. Cold plunge helps soreness but can blunt muscle gains. Here is what the evidence supports and what it does not.
Read More
The first six weeks on an SSRI are where most people quit. Here is what actually happens, when to expect improvement, and which side effects fade and which do not.
Read More
A flagged value is not a diagnosis. Here is how to read a standard blood panel, what the reference range actually means, and which abnormal results matter.
Read More
Tretinoin is one of the few skincare ingredients with decades of trial data behind it. Here is what it actually does, how long it takes, and how to start without wrecking your skin.
Read More
Nausea, fullness, and constipation are expected on semaglutide. Severe pain, repeated vomiting, and vision changes are not. Here is how to tell them apart.
Read More
Standard testosterone therapy can quietly shut down sperm production. Clomiphene, enclomiphene, and hCG raise your own testosterone while protecting fertility.
Read More
Fiber, probiotics, test kits, cleanses. Here is what the evidence actually supports for gut health, what it does not, and the symptoms that need a real workup.
Read More
IV ketamine and esketamine (Spravato) are close cousins, not the same treatment. Here is how they differ in delivery, rules, evidence, and cost.
Read More
Prediabetes affects roughly 1 in 3 US adults, and most do not know they have it. Here is how it is detected and what the evidence says you can do.
Read More
Beyond price-per-syringe: how patient-reported outcomes and quality-of-life research help you choose aesthetic treatments that deliver real results.
Read More
New research links semaglutide and tirzepatide to changes in mood, cognition, and addiction. Here is what the evidence says -- and what we monitor.
Read More
A calm, practical guide to checking your testicles, telling a harmless lump from a worrying one, and knowing exactly when to get seen.
Read More
A clinician's honest guide to better sleep -- what the evidence supports, what to ignore, and when snoring or daytime sleepiness means it is time to test.
Read More
Depression treatment is shifting fast. Dr. Jezwah Harris breaks down what the evidence says about ketamine, esketamine, psychedelic-assisted therapy, and precision psychiatry.
Read More
What the two numbers mean, which category you fall into, how to measure correctly at home, and when the answer is lifestyle versus medication.
Read More
Natural lip filler is about restraint and anatomy, not volume. Here is how conservative dosing, technique, and injector skill keep results looking like you.
Read More
A 2025 retrospective cohort study compared all three options head-to-head. Here is what the numbers mean for you and how we think about the choice.
Read More
Worried testosterone therapy will strain your heart? Here is what the 2023 TRAVERSE trial and FDA labeling actually say, and how we monitor for it at NBH.
Read More
The anti-inflammatory diet has been oversold. Here is what the research actually supports, why single superfoods fall short, and where supplements fit.
Read More
New observational data on telehealth-supported at-home ketamine for depression, anxiety, and PTSD -- what it shows, what it misses, and who it may help.
Read More
A plain-language guide to reading your lipid panel -- LDL, HDL, triglycerides, non-HDL, ApoB, and Lp(a) -- and what those numbers say about your heart risk.
Read More
Filler reactions range from mild swelling to delayed granulomas. Here is what the evidence says about risk, recognition, and management.
Read More
GLP-1 drugs like Wegovy and Zepbound can run over $1,000 a month. Here is what the efficacy and cost-effectiveness evidence actually says about value.
Read More
Do over-the-counter testosterone boosters work? Here is what the evidence shows on tribulus, fenugreek, ashwagandha, and zinc, and when to test instead.
Read More
Most people with a decent diet do not need most supplements. Here is how to decide which ones are worth it, using testing and evidence instead of guesswork.
Read More
KAP is not a magic reset. Here is what the clinical data shows, how sessions actually work, and who is -- and is not -- a good candidate.
Read More
Fulminant myocarditis can strike without a COVID diagnosis. We break down the triggers, warning signs, and what a thorough workup looks like.
Read More
A plain-language guide to superficial, medium, and deep chemical peels -- which acids treat what, realistic downtime, and how to stay safe in darker skin.
Read More
New pharmacokinetic modeling shows how semaglutide and tirzepatide doses stack up for weight loss in type 2 diabetes -- and what that means in clinical practice.
Read More
Tired all the time and wondering if it is low testosterone? Often it is not. Here is how a careful clinician works up male fatigue before treating.
Read More
Most supplements do little unless you are truly low. Here is when magnesium, vitamin D, and B12 actually help, and why testing comes before the pill.
Read More
New rat studies raise questions about age-related neurotoxicity with ketamine. Here is what the evidence actually says for adult patients considering ketamine therapy.
Read More
A mildly high CRP is common and usually nonspecific. Here is what CRP, hs-CRP, and ESR actually measure, what raises them, and when a result matters.
Read More
The MUST trial's 5-year data reframes how clinicians think about overactive bladder after sling surgery. Here is what the findings mean in plain language.
Read More
GLP-1 receptor agonists do more than lower blood sugar. Here is what large cardiovascular outcome trials and a 2025 network meta-analysis show about heart risk.
Read More
TRT alone changes the hormonal picture. Add structured exercise and the body-composition data shifts meaningfully. Here is what the evidence actually shows.
Read More
A 2025 RCT tested NAD+ precursor supplementation and individualised exercise in Friedreich's ataxia. Here is what the findings mean for you.
Read More
An evidence-based, age-by-age guide to the preventive screenings worth doing after 40, grounded in USPSTF guidelines and honest about what to skip.
Read More
An honest, evidence-based look at the three most-talked-about peptides in functional medicine. What human research shows, what is still mouse data, and how to think about safety.
Read More
An honest clinical guide to peptide therapy for men: how BPC-157, CJC-1295, and ipamorelin actually work, the FDA reality, real costs, and who should skip them.
Read More
Stalled on Wegovy or Zepbound? A clinician's guide to why GLP-1 plateaus happen, what the data actually says, and the moves that get the scale moving again.
Read More
A clinician's guide to dermal fillers in 2026: how HA fillers, Sculptra, and Radiesse actually work, real cost ranges, results timelines, risks, and how to pick a safe injector.
Read More
A clear, evidence-based guide to TRT: who actually benefits, what blood work matters, what to expect month by month, and the risks worth respecting.
Read More
How adult ADHD is actually diagnosed, what treatment looks like beyond stimulants, and why so many adults (especially women) get missed for decades.
Read More
Wegovy or Zepbound? We compare semaglutide and tirzepatide head-to-head on weight loss, side effects, cost, and who should pick which one.
Read More
Updated 2026 guide to high blood pressure treatment: 2025 AHA/ACC targets, lifestyle that actually moves the needle, first-line drugs, resistant cases, and what to expect.
Read More
A clinician's guide to Botox in 2026: how it works, what it treats, real costs, the differences between Botox, Dysport, Xeomin, Daxxify, and Jeuveau, and what your first visit actually looks like.
Read More
Hot flashes, sleep loss, brain fog, weight gain, mood swings. A practical, evidence-based look at what perimenopause actually is and what hormone therapy can and can't do.
Read More
What NAD+ actually does, what the human research shows, and how IV vs oral precursors like NMN and NR compare. Honest, evidence-based answers.
Read More
An honest look at ketamine for treatment-resistant depression: how it works, response rates, side effects, cost, and who actually benefits.
Read More
Fatigue, low libido, brain fog. Five evidence-based signs of low testosterone in men, what else could explain them, and when lab work makes sense.
Read More
Why fad diets keep failing and how a structured medical weight loss program uses labs, behavior coaching, and clinician oversight to make results stick.
Read More
A clinician's guide to adult acne in 2026: why it shows up at 30 or 45, what's actually causing it, when to stop relying on OTC products, and which prescription treatments actually work.
Read More
A clinical, judgment-free look at ED in 2026: what causes it, which treatments actually work, real costs, side effects worth respecting, and how to start.
Read More
An honest look at IV vitamin drips, the Myers cocktail, and high-dose vitamin C. What the human evidence shows, where the placebo response lives, and when an IV is worth your money.
Read More
Feeling fine is not the same as being well. A clear, evidence-based look at what an annual physical actually catches, what to ask for, and what concierge care changes.
Read MoreSubscribe to our newsletter for the latest health insights and updates.
Our providers are here to answer your questions and help you find the right treatment plan.